Celularity Inc FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Jun 21, 2022
  • Last warning letter 2025
Inspections 4 0 OAI
Recalls 0 0 Class I
Warning letters 1 Latest Dec 1, 2025
510(k) clearances 0 None on file

Celularity Inc has 0 FDA recalls, 4 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Celularity Inc, the most recent on Dec 1, 2025.

What these totals cover: FDA records filed under the name "Celularity Inc" and its spelling variant "Celularity".

Latest inspection
Jun 21, 2022 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections4Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Celularity Inc's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Celularity Inc: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 1 warning letter, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500100
202400000
202300000
202210000
202100000
202000000
201910000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Celularity Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Celularity Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Celularity Inc FDA Warning Letters

1 warning letter on Dec 1, 2025.

IssuedSubjectIssuing officeClose-out letter
Dec 1, 2025 · Letter on fda.gov Unapproved New Drug/Unlicensed Biological Product/Biologics License Application (BLA)Office of Compliance and Biologics Quality

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent FDA inspections

4 inspections from Jan 20, 2010 to Jun 21, 2022.

DateSiteProductClassificationFEI
Jun 21, 2022Florham Park, NJBiologicsNo Action Indicated (NAI)3016661001
Apr 29, 2019Florham Park, NJBiologicsNo Action Indicated (NAI)3016661001
Nov 2, 2016Florham Park, NJBiologicsNo Action Indicated (NAI)3016661001
Jan 20, 2010Florham Park, NJBiologicsNo Action Indicated (NAI)3016661001
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Celularity Inc: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Dec 1, 2025.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3016661001Florham Park, NJ4Jun 21, 2022

Celularity Inc and the FDA: common questions

Has Celularity Inc received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Celularity Inc. The most recent is dated Dec 1, 2025, with the subject "Unapproved New Drug/Unlicensed Biological Product/Biologics License Application (BLA)".

Has Celularity Inc received an FDA Form 483?

FDA has not published a Form 483 for "Celularity Inc" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Celularity Inc?

The most recent FDA inspection on file ended Jun 21, 2022 at Florham Park, NJ and was classified NAI. FDA has 4 inspections of Celularity Inc on file.

Need more than this page shows? Ask about Celularity Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.